European Journal of Haematology, 1600-0609

Journal

More filtering options
  1. Article
  2. Low response rate to ATG-based immunosuppressive therapy in very severe aplastic anaemia - A Swedish nationwide cohort study

    Vaht, K., Göransson, M., Carlson, K., Isaksson, C., Lenhoff, S., Sandstedt, A., Uggla, B., Winiarski, J., Ljungman, P., Brune, M. & Andersson, P. O., 2018, In : European Journal of Haematology. 100, 6, p. 613-620

    Research output: Contribution to journalArticle

  3. Adverse event management in patients with relapsed and refractory multiple myeloma taking pomalidomide plus low-dose dexamethasone: A pooled analysis

    Moreau, P., Dimopoulos, M. A., Richardson, P. G., Siegel, D. S., Cavo, M., Corradini, P., Weisel, K. C., Delforge, M., O'Gorman, P., Song, K., Chen, C., Bahlis, N., Oriol, A., Hansson, M., Kaiser, M., Anttila, P., Raymakers, R., Joao, C., Cook, G., Sternas, L. & 7 othersBiyukov, T., Slaughter, A., Hong, K., Herring, J., Yu, X., Zaki, M. H. & San Miguel, J., 2017 Sep 1, In : European Journal of Haematology. 99, 3, p. 199-206 8 p.

    Research output: Contribution to journalArticle

  4. Incidence, characteristics, and outcome of solitary plasmacytoma and plasma cell leukemia. Population-based data from the Swedish Myeloma Register

    Nahi, H., Genell, A., Wålinder, G., Uttervall, K., Gunnar Juliusson, Karin, F., Markus Hansson, Svensson, R., Linder, O., Carlson, K., Björkstrand, B., Kristinsson, S. Y., Mellqvist, U-H., Blimark, C. & Ingemar Turesson, 2017 Sep, In : European Journal of Haematology. 99, 3, p. 216-222

    Research output: Contribution to journalArticle

  5. Age but not Philadelphia positivity impairs outcome in older/elderly patients with acute lymphoblastic leukemia in Sweden

    Kozlowski, P., Lennmyr, E., Ahlberg, L., Bernell, P., Hulegårdh, E., Karbach, H., Karlsson, K., Tomaszewska-Toporska, B., Åström, M., Hallböök, H. & the Swedish Adult Acute Lymphoblastic Leukemia Group (SVALL), 2017 Aug 1, In : European Journal of Haematology. 99, 2, p. 141-149 9 p.

    Research output: Contribution to journalArticle

  6. Genomewide association study on monoclonal gammopathy of unknown significance (MGUS)

    Hauke Thomsen, Campo, C., Weinhold, N., da Silva Filho, M. I., Pour, L., Gregora, E., Vodicka, P., Vodickova, L., Hoffmann, P., Nöthen, M. M., Jöckel, K-H., Langer, C., Hajek, R., Goldschmidt, H., Kari Hemminki & Asta Försti, 2017 Jul, In : European Journal of Haematology. 99, 1, p. 70-79 10 p.

    Research output: Contribution to journalArticle

  7. The second Team Haemophilia Education Meeting, 2016, Frankfurt, Germany

    Berntorp, E., Dargaud, Y., Hart, D. P., Lobet, S., Mancuso, M. E., d'Oiron, R., Perry, D., Pollard, D., van den Berg, M., Blatný, J., Chambost, H., Doria, A. S., Holme, P. A., Kaczmarek, R., Mantovani, L., McLaughlin, P., Nanayakkara, L., Petrini, P., Sannié, T., Laane, E. & 6 othersMaia, R., Dettoraki, A., Farrell, A., Halimeh, S., Raza, S. & Taylor, S., 2017 Jan 1, In : European Journal of Haematology. 98, s85, p. 1-15 15 p.

    Research output: Contribution to journalArticle

  8. Patient-tailored analysis of minimal residual disease in acute myeloid leukemia using next-generation sequencing

    Malmberg, E. B. R., Ståhlman, S., Rehammar, A., Samuelsson, T., Alm, S. J., Kristiansson, E., Abrahamsson, J., Garelius, H., Louise Pettersson, Mats Ehinger, Palmqvist, L. & Fogelstrand, L., 2017 Jan, In : European Journal of Haematology. 98, 1, p. 26-37

    Research output: Contribution to journalArticle

  9. Advanced phase chronic myeloid leukaemia (CML) in the tyrosine kinase inhibitor era - a report from the Swedish CML register

    Söderlund, S., Dahlén, T., Sandin, F., Olsson-Strömberg, U., Creignou, M., Dreimane, A., Lübking, A., Markevärn, B., Själander, A., Wadenvik, H., Stenke, L., Johan Richter & Höglund, M., 2017 Jan, In : European Journal of Haematology. 98, 1, p. 57-66

    Research output: Contribution to journalArticle

  10. Von Willebrand disease - the 'Dos' and 'Don'ts' in surgery

    Miesbach, W. & Erik Berntorp, 2017, In : European Journal of Haematology. 98, 2, p. 121-127

    Research output: Contribution to journalArticle

  11. The impact of socio-economic factors on treatment choice and mortality in chronic myeloid leukaemia

    Larfors, G., Sandin, F., Johan Richter, Själander, A., Stenke, L., Lambe, M. & Höglund, M., 2017, In : European Journal of Haematology. 98, 4, p. 398-406 9 p.

    Research output: Contribution to journalArticle

  12. Incidence and prognostic significance of isolated trisomies in adult acute myeloid leukemia: A population-based study from the Swedish AML registry

    Lj Lazarevic, V., Aldana Rosso, Gunnar Juliusson, Antunovic, P., Derolf, Å. R., Deneberg, S., Möllgård, L., Uggla, B., Wennström, L., Wahlin, A., Höglund, M., Lehmann, S. & Bertil Johansson, 2017, In : European Journal of Haematology. 98, 5, p. 493-500

    Research output: Contribution to journalArticle

  13. Primary cells in BCR/FGFR1-positive 8p11 myeloproliferative syndrome are sensitive to dovitinib, ponatinib, and dasatinib

    Niklas Landberg, Dreimane, A., Rissler, M., Billström, R. & Helena Ågerstam, 2017, In : European Journal of Haematology. 99, 5, p. 442-448 7 p.

    Research output: Contribution to journalArticle

  14. The first Team Haemophilia Education meeting, 2015, Amsterdam, The Netherlands

    Erik Berntorp, Hart, D., Mancuso, M. E., d'Oiron, R., Perry, D., O'Mahony, B., Kaczmarek, R., Crato, M., Pasi, J., Miners, A., Katarina Steen Carlsson, Kitchen, S., Boehlen, F., Giangrande, P., Cebura, E., Uitslager, N., Mehdi Osooli, Janeckova, D., Haldon, R. & Rivolta, G. F., 2016 Jul 1, In : European Journal of Haematology. 97, p. 3-18 16 p.

    Research output: Contribution to journalArticle

  15. Population-based assessment of chronic myeloid leukemia in Sweden: striking increase in survival and prevalence.

    Gunnarsson, N., Sandin, F., Höglund, M., Stenke, L., Björkholm, M., Lambe, M., Olsson-Strömberg, U., Johan Richter & Själander, A., 2016, In : European Journal of Haematology. 97, 4, p. 387-392

    Research output: Contribution to journalArticle

  16. Interaction between VWF and FVIII in treating VWD

    Miesbach, W. & Erik Berntorp, 2015, In : European Journal of Haematology. 95, 5, p. 449-454

    Research output: Contribution to journalArticle

  17. Failure matters: unsuccessful cytogenetics and unperformed cytogenetics are associated with a poor prognosis in a population-based series of acute myeloid leukaemia.

    Lazarevic, V., Hörstedt, A., Bertil Johansson, Antunovic, P., Billström, R., Derolf, A., Lehmann, S., Möllgård, L., Peterson, S., Stockelberg, D., Uggla, B., Vennström, L., Wahlin, A., Höglund, M. & Gunnar Juliusson, 2015, In : European Journal of Haematology. 94, 5, p. 419-423

    Research output: Contribution to journalArticle

  18. Dasatinib induces fast and deep responses in newly diagnosed chronic myeloid leukaemia patients in chronic phase: clinical results from a randomised phase-2 study (NordCML006)

    Hjorth-Hansen, H., Stenke, L., Soderlund, S., Dreimane, A., Hans Ehrencrona, Gedde-Dahl, T., Gjertsen, B. T., Hoglund, M., Koskenvesa, P., Lotfi, K., Majeed, W., Markevarn, B., Ohm, L., Olsson-Stromberg, U., Remes, K., Suominen, M., Simonsson, B., Porkka, K., Mustjoki, S. & Johan Richter, 2015, In : European Journal of Haematology. 94, 3, p. 243-250

    Research output: Contribution to journalArticle

  19. High relapse rate of T cell acute lymphoblastic leukemia in adults treated with Hyper-CVAD chemotherapy in Sweden

    Kozlowski, P., Astrom, M., Ahlberg, L., Bernell, P., Hulegardh, E., Hagglund, H., Karlsson, K., Markuszewska-Kuczymska, A., Tomaszewska-Toporska, B., Smedmyr, B., Amini, R-M. & Hallbook, H., 2014, In : European Journal of Haematology. 92, 5, p. 377-381

    Research output: Contribution to journalArticle

  20. Angiogenesis is increased in advanced haemophilic joint disease and characterized by normal pericyte coverage.

    Eva Zetterberg, Palmblad, J., Wallensten, R., Morfini, M., Melchiorre, D. & Holmström, E. M., 2014, In : European Journal of Haematology. 92, 3, p. 256-262

    Research output: Contribution to journalArticle

  21. Outcomes in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with isolated deletion 5q treated with lenalidomide: a subset analysis from the MDS-004 study

    Giagounidis, A., Mufti, G. J., Mittelman, M., Sanz, G., Platzbecker, U., Muus, P., Selleslag, D., Beyne-Rauzy, O., te Boekhorst, P., del Canizo, C., Guerci-Bresler, A., Nilsson, L., Luebbert, M., Quesnel, B., Ganser, A., Bowen, D., Schlegelberger, B., Goehring, G., Fu, T., Benettaib, B. & 2 othersHellstrom-Lindberg, E. & Fenaux, P., 2014, In : European Journal of Haematology. 93, 5, p. 429-438

    Research output: Contribution to journalArticle

  22. Outcome of poor response paediatric AML using early SCT

    Wareham, N. E., Heilmann, C., Abrahamsson, J., Forestier, E., Gustafsson, B., Ha, S-Y., Heldrup, J., Jahnukainen, K., Jonsson, O. G., Lausen, B., Palle, J., Zeller, B. & Hasle, H., 2013, In : European Journal of Haematology. 90, 3, p. 187-194

    Research output: Contribution to journalArticle

  23. High serum vascular endothelial growth factor level is an adverse prognostic factor for high-risk diffuse large B-cell lymphoma patients treated with dose-dense chemoimmunotherapy

    Riihijarvi, S., Nurmi, H., Holte, H., Bjorkholm, M., Fluge, O., Pedersen, L. M., Fjordén, K., Mats Jerkeman, Mikael Eriksson & Leppa, S., 2012, In : European Journal of Haematology. 89, 5, p. 395-402

    Research output: Contribution to journalArticle

  24. Immune tolerance induction in patients with severe hemophilia with inhibitors: expert panel views and recommendations for clinical practice.

    Benson, G., Auerswald, G., Elezović, I., Lambert, T., Rolf Ljung, Morfini, M., Remor, E. & Salek, S. Z., 2012, In : European Journal of Haematology. 88, 5, p. 371-379

    Research output: Contribution to journalArticle

  25. Angptl4 maintains in vivo repopulation capacity of CD34(+) human cord blood cells.

    Blank Savukinas, U., Ehrnström, B., Heinz, N., Nilsson, E. C., Brun, A., Baum, C., Schiedlmeier, B. & Stefan Karlsson, 2012, In : European Journal of Haematology. 89, 3, p. 198-205

    Research output: Contribution to journalArticle

  26. Male gender is an adverse prognostic factor in B-cell lymphoma patients treated with immunochemotherapy

    Riihijarvi, S., Taskinen, M., Mats Jerkeman & Leppa, S., 2011, In : European Journal of Haematology. 86, 2, p. 124-128

    Research output: Contribution to journalArticle

  27. Quality of life, physical function and MRI T2*in elderly low-risk MDS patients treated to a haemoglobin level of >= 120 g/L with darbepoetin alfa +/- filgrastim or erythrocyte transfusions

    Nilsson-Ehle, H., Birgegård, G., Samuelsson Johannesson, J., Antunovic, P., Jan Astermark, Garelius, H., Engström, L., Kjeldsen, L., Nilsson, L., Olsson, A., Skov-Holm, M., Wallvik, J., Gulbrandsen, N. & Hellström-Lindberg, E., 2011, In : European Journal of Haematology. 87, 3, p. 244-252

    Research output: Contribution to journalArticle

  28. When von Willebrand disease comes into age - A matter of change?

    Miesbach, W. & Erik Berntorp, 2011, In : European Journal of Haematology. 86, p. 496-501

    Research output: Contribution to journalArticle

  29. Applicability of IG/TCR gene rearrangements as targets for minimal residual disease assessment in a population-based cohort of Swedish childhood acute lymphoblastic leukaemia diagnosed 2002-2006

    Thorn, I., Forestier, E., Thuresson, B., Wasslavik, C., Malec, M., Li, A., Lindstrom-Eriksson, E., Botling, J., Barbany, G., Jacobsson, S., Olofsson, T., Porwit, A., Sundstrom, C. & Rosenquist, R., 2010, In : European Journal of Haematology. 84, 2, p. 117-127

    Research output: Contribution to journalArticle

  30. MDM2 SNP309 promoter polymorphism, an independent prognostic factor in chronic lymphocytic leukemia

    Willander, K., Ungerback, J., Karlsson, K., Fredrikson, M., Soderkvist, P. & Linderholm, M., 2010, In : European Journal of Haematology. 85, 3, p. 251-256

    Research output: Contribution to journalArticle

  31. Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study

    Wahlin, A., Billstrom, R., Bjor, O., Ahlgren, T., Hedenus, M., Hoglund, M., Lindmark, A., Markevarn, B., Nilsson, B., Sallerfors, B. & Brune, M., 2009, In : European Journal of Haematology. 83, 2, p. 99-107

    Research output: Contribution to journalArticle

  32. Bcl-2 but not FOXP1, is an adverse risk factor in immunochemotherapy-treated non-germinal center diffuse large B-cell lymphomas

    Nyman, H., Mats Jerkeman, Karjalainen-Lindsberg, M-L., Banham, A. H., Enblad, G. & Leppa, S., 2009, In : European Journal of Haematology. 82, 5, p. 364-372

    Research output: Contribution to journalArticle

  33. U-2973, a novel B-cell line established from a patient with a mature B-cell leukemia displaying concurrent t(14;18) and MYC translocation to a non-IG gene partner.

    Hans Ehrencrona, Leuchowius, K-J., Hallböök, H., Nordgren, A., Thörn, I., Thorselius, M., Rosenquist, R., Söderberg, O. & Sundström, C., 2008, In : European Journal of Haematology. 81, 3, p. 218-225

    Research output: Contribution to journalArticle

  34. Tissue microarray is inappropriate for analysis of BCL6 expression in diffuse large B-cell lymphoma.

    Linderoth, J., Mats Ehinger, Åkerman, M., Cavallin-Ståhl, E., Enblad, G., Erlanson, M. & Mats Jerkeman, 2007, In : European Journal of Haematology. 79, 2, p. 146-149

    Research output: Contribution to journalArticle

  35. Serum calcium is an independent predictor of quality of life in multiple myeloma

    Wisloff, F., Kvam, A. K., Hjorth, M. & Lenhoff, S., 2007, In : European Journal of Haematology. 78, 1, p. 29-34

    Research output: Contribution to journalArticle

  36. Deregulation of cyclin D2 by juxtaposition with T-cell receptor alpha/delta locus in t(12;14)(p13;q11)-positive childhood T-cell acute lymphoblastic leukemia.

    Karrman, K., Anna Andersson, Björgvinsdottir, H., Strömbeck, B., Lassen, C., Olofsson, T., Nguyen-Khac, F., Berger, R., Bernard, O., Thoas Fioretos & Bertil Johansson, 2006, In : European Journal of Haematology. 77, 1, p. 27-34

    Research output: Contribution to journalArticle

  37. Serum YKL-40 concentrations in newly diagnosed multiple myeloma patients and YKL-40 expression in malignant plasma cells

    Mylin, A. K., Rasmussen, T., Johansen, J. S., Knudsen, L. M., Norgaard, P. H., Lenhoff, S., Dahl, I. M. S. & Johnsen, H. E., 2006, In : European Journal of Haematology. 77, 5, p. 416-424

    Research output: Contribution to journalArticle

  38. Quality of life may be affected more by disease parameters and response to therapy than by haemoglobin changes

    Wisloff, F., Gulbrandsen, N., Hjorth, M., Lenhoff, S. & Fayers, P., 2005, In : European Journal of Haematology. 75, 4, p. 293-298

    Research output: Contribution to journalArticle

  39. Management of patients with polycythaemia vera: results of a survey among Swedish haematologists

    Andreasson, B., Lofvenberg, E. & Westin, J., 2005, In : European Journal of Haematology. 74, 6, p. 489-495

    Research output: Contribution to journalArticle

  40. Expression of cyclin A1 and cell cycle proteins in hematopoietic cells and acute myeloid leukemia and links to patient outcome.

    Ekberg, J., Wigerup, C., Jalili, S., Johan Richter, Anagnostaki, L., Landberg, G. & Persson, J. L., 2005, In : European Journal of Haematology. 75, 2, p. 106-115

    Research output: Contribution to journalArticle

Previous 1 2 3 Next